Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2
Arif Jamal Siddiqui, Sadaf Jahan, Syed Amir Ashraf, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 17, pp. 6828-6841
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

COVID-19, cytokines, inflammation, and spices: How are they related?
Ajaikumar B. Kunnumakkara, Varsha Rana, Parama Dey, et al.
Life Sciences (2021) Vol. 284, pp. 119201-119201
Open Access | Times Cited: 96
Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: A cross-sectional survey
Magaly Villena-Tejada, Ingrid Vera-Ferchau, Anahí Cardona-Rivero, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257165-e0257165
Open Access | Times Cited: 90
A systematic review on AI/ML approaches against COVID-19 outbreak
Onur Doğan, Sanju Tiwari, M. A. Jabbar, et al.
Complex & Intelligent Systems (2021) Vol. 7, Iss. 5, pp. 2655-2678
Open Access | Times Cited: 74
Current understanding of the influence of environmental factors on SARS-CoV-2 transmission, persistence, and infectivity
Sanjeev Kumar, Ritu Singh, Nisha Kumari, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 6, pp. 6267-6288
Open Access | Times Cited: 71
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
Nada A. Ashour, Ayman Abo Elmaaty, Amany A. Sarhan, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 685-715
Open Access | Times Cited: 40
Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses
Arif Jamal Siddiqui, Corina Danciu, Syed Amir Ashraf, et al.
Plants (2020) Vol. 9, Iss. 9, pp. 1244-1244
Open Access | Times Cited: 62
Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19
Dipak Kumar, Sadaf Jahan, Andleeb Khan, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 7, pp. 3417-3434
Open Access | Times Cited: 49
Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19
Zaki F. Aref, Shamardan Ezzeldin S. Bazeed, Mohammed H. Hassan, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4063-4072
Open Access | Times Cited: 47
RETRACTED: Use of ivermectin in the treatment of Covid-19: A pilot trial
Henrique Pott, Mônica Maria Bastos Paoliello, Alice de Queiroz Constantino Miguel, et al.
Toxicology Reports (2021) Vol. 8, pp. 505-510
Open Access | Times Cited: 43
Emergence of SARS-CoV-2 New Variants and Their Clinical Significance
Hitesh Singh, Nisha Dahiya, Mahima Yadav, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 32
A novel perspective approach to explore pros and cons of face mask in prevention the spread of SARS-CoV-2 and other pathogens
Md Faruque Ahmad, Shadma Wahab, Fakhruddin Ali Ahmad, et al.
Saudi Pharmaceutical Journal (2020) Vol. 29, Iss. 2, pp. 121-133
Open Access | Times Cited: 44
Vaccines for COVID-19: A Systematic Review of Feasibility and Effectiveness
Esmaeil Mehraeen, Omid Dadras, Amir Masoud Afsahi, et al.
Infectious Disorders - Drug Targets (2021) Vol. 22, Iss. 2
Closed Access | Times Cited: 40
Biflavonoids from Rhus succedanea as probable natural inhibitors against SARS-CoV-2: a molecular docking and molecular dynamics approach
Kiran Bharat Lokhande, Neelu Nawani, Swamy K. Venkateswara, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 10, pp. 4376-4388
Open Access | Times Cited: 39
Coronavirus Disease (COVID-19) Control between Drug Repurposing and Vaccination: A Comprehensive Overview
Ahmed A. Al‐Karmalawy, Raya Soltane, Ayman Abo Elmaaty, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1317-1317
Open Access | Times Cited: 39
Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications
Rajnish Kumar, Anju Sharma, Janmejai Kumar Srivastava, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 30, pp. 40431-40444
Open Access | Times Cited: 34
Elucidating of oxidative distress in COVID-19 and methods of its prevention
Anna‐Maria Barciszewska
Chemico-Biological Interactions (2021) Vol. 344, pp. 109501-109501
Open Access | Times Cited: 26
Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility
Rajalakshmi Rajendran, Anjana Chathambath, Abdullah G. Al‐Sehemi, et al.
Environmental Science and Pollution Research (2022) Vol. 29, Iss. 26, pp. 38657-38672
Open Access | Times Cited: 18
Nitazoxanide as an early treatment to reduce the intensity of COVID‑19 outbreaks among health personnel
Hugo Mendieta Zerón, José Meneses Calderón, Leopoldo Paniagua Coria, et al.
World Academy of Sciences Journal (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 21
Analytical approaches for determination of COVID-19 candidate drugs in human biological matrices
Rabee Mahdavi, Zahra Talebpour
TrAC Trends in Analytical Chemistry (2023) Vol. 160, pp. 116964-116964
Open Access | Times Cited: 8
Reducing SARS-CoV-2 pathological protein activity with small molecules
Donata Pluskota‐Karwatka, Marcin Hoffmann, Jan Barciszewski
Journal of Pharmaceutical Analysis (2021) Vol. 11, Iss. 4, pp. 383-397
Open Access | Times Cited: 15
SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation
Nancy Fayad, Walid Abi Habib, Ahmed Kandeil, et al.
Biology (2021) Vol. 10, Iss. 6, pp. 531-531
Open Access | Times Cited: 14
Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review
Subhrojyoti Bhowmick, Amit Dang, BN Vallish, et al.
Drug Safety (2021) Vol. 44, Iss. 6, pp. 635-644
Open Access | Times Cited: 14
Oxytocin, the panacea for long-COVID? a review
Phuoc-Tan Diep, Mohammed Chaudry, Adam Dixon, et al.
Hormone Molecular Biology and Clinical Investigation (2022) Vol. 43, Iss. 3, pp. 363-371
Open Access | Times Cited: 9
Spotlight on 4‐substituted quinolines as potential anti‐infective agents: Journey beyond chloroquine
Ankush Goyal, Harsha Kharkwal, Mona Piplani, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 3
Closed Access | Times Cited: 8
Can Non-steroidal Anti-inflammatory Drugs Affect the Interaction Between Receptor Binding Domain of SARS-COV-2 Spike and the Human ACE2 Receptor? A Computational Biophysical Study
Lenin González-Paz, Carla Lossada, Francelys V. Fernández-Materán, et al.
Frontiers in Physics (2020) Vol. 8
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top